202 related articles for article (PubMed ID: 32905326)
21. A Novel Dynamic Neonatal Blood-Brain Barrier on a Chip.
Deosarkar SP; Prabhakarpandian B; Wang B; Sheffield JB; Krynska B; Kiani MF
PLoS One; 2015; 10(11):e0142725. PubMed ID: 26555149
[TBL] [Abstract][Full Text] [Related]
22. Amphiphilic HPMA-LMA copolymers increase the transport of Rhodamine 123 across a BBB model without harming its barrier integrity.
Hemmelmann M; Metz VV; Koynov K; Blank K; Postina R; Zentel R
J Control Release; 2012 Oct; 163(2):170-7. PubMed ID: 22981565
[TBL] [Abstract][Full Text] [Related]
23. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
Shawahna R; Decleves X; Scherrmann JM
Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
[TBL] [Abstract][Full Text] [Related]
24. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents.
Cho CF; Wolfe JM; Fadzen CM; Calligaris D; Hornburg K; Chiocca EA; Agar NYR; Pentelute BL; Lawler SE
Nat Commun; 2017 Jun; 8():15623. PubMed ID: 28585535
[TBL] [Abstract][Full Text] [Related]
25. A pump-free tricellular blood-brain barrier on-a-chip model to understand barrier property and evaluate drug response.
Yu F; Kumar NDS; Foo LC; Ng SH; Hunziker W; Choudhury D
Biotechnol Bioeng; 2020 Apr; 117(4):1127-1136. PubMed ID: 31885078
[TBL] [Abstract][Full Text] [Related]
26. Patented in vitro blood-brain barrier models in CNS drug discovery.
Tóth A; Veszelka S; Nakagawa S; Niwa M; Deli MA
Recent Pat CNS Drug Discov; 2011 May; 6(2):107-18. PubMed ID: 21585327
[TBL] [Abstract][Full Text] [Related]
27. A Novel Transwell Blood Brain Barrier Model Using Primary Human Cells.
Stone NL; England TJ; O'Sullivan SE
Front Cell Neurosci; 2019; 13():230. PubMed ID: 31244605
[TBL] [Abstract][Full Text] [Related]
28. Modeling the blood-brain barrier using stem cell sources.
Lippmann ES; Al-Ahmad A; Palecek SP; Shusta EV
Fluids Barriers CNS; 2013 Jan; 10(1):2. PubMed ID: 23305164
[TBL] [Abstract][Full Text] [Related]
29. Transport Across the Blood-Brain Barrier.
Fu BM
Adv Exp Med Biol; 2018; 1097():235-259. PubMed ID: 30315549
[TBL] [Abstract][Full Text] [Related]
30. Modeling the blood-brain barrier: Beyond the endothelial cells.
Gastfriend BD; Palecek SP; Shusta EV
Curr Opin Biomed Eng; 2018 Mar; 5():6-12. PubMed ID: 29915815
[TBL] [Abstract][Full Text] [Related]
31. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
32. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
[TBL] [Abstract][Full Text] [Related]
33. Blood-brain barrier: transport studies in isolated brain capillaries and in cultured brain endothelial cells.
Takakura Y; Audus KL; Borchardt RT
Adv Pharmacol; 1991; 22():137-65. PubMed ID: 1958501
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the brain-to-blood efflux transport across the blood-brain barrier.
Hosoya K; Ohtsuki S; Terasaki T
Int J Pharm; 2002 Nov; 248(1-2):15-29. PubMed ID: 12429456
[TBL] [Abstract][Full Text] [Related]
35. Application of in vivo brain microdialysis to the study of blood-brain barrier transport of drugs.
Deguchi Y
Drug Metab Pharmacokinet; 2002; 17(5):395-407. PubMed ID: 15618691
[TBL] [Abstract][Full Text] [Related]
36. ATA2 is predominantly expressed as system A at the blood-brain barrier and acts as brain-to-blood efflux transport for L-proline.
Takanaga H; Tokuda N; Ohtsuki S; Hosoya K; Terasaki T
Mol Pharmacol; 2002 Jun; 61(6):1289-96. PubMed ID: 12021389
[TBL] [Abstract][Full Text] [Related]
37. Effect of Nanoparticle Composition, Size, Shape, and Stiffness on Penetration Across the Blood-Brain Barrier.
Brown TD; Habibi N; Wu D; Lahann J; Mitragotri S
ACS Biomater Sci Eng; 2020 Sep; 6(9):4916-4928. PubMed ID: 33455287
[TBL] [Abstract][Full Text] [Related]
38. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
[TBL] [Abstract][Full Text] [Related]
39. Microphysiological systems for recapitulating physiology and function of blood-brain barrier.
Seo S; Kim H; Sung JH; Choi N; Lee K; Kim HN
Biomaterials; 2020 Feb; 232():119732. PubMed ID: 31901694
[TBL] [Abstract][Full Text] [Related]
40. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
